Welcome to our dedicated page for Ventas SEC filings (Ticker: VTR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Ventas’ filings can feel like sorting through hundreds of pages on rent escalators, triple-net lease covenants, and senior-housing occupancy rates. If you’ve ever asked, “Where’s the dividend guidance hidden in Ventas’ annual report 10-K?” or hunted for Ventas insider trading Form 4 transactions, you know the challenge.
Stock Titan solves it. Our platform ingests every Ventas quarterly earnings report 10-Q filing, 8-K, and proxy in real time, then delivers plain-English, AI-powered summaries. Need Ventas Form 4 insider transactions real-time? Get instant alerts. Trying to compare deferred rent trends quarter over quarter? Our AI highlights the numbers and adds context so you’re understanding Ventas SEC documents with AI instead of decoding footnotes.
You’ll find more than a list of forms. We connect each document to what matters for a healthcare REIT: the 10-K section that forecasts SHOP margins, the 8-K paragraph announcing operator restructurings (Ventas 8-K material events explained), or the Ventas proxy statement executive compensation table that details incentive targets. Whether you’re scanning a Ventas annual report 10-K simplified for dividend coverage or running a quick Ventas earnings report filing analysis, the insights are ready in minutes—no spreadsheet gymnastics required. Monitor Ventas executive stock transactions Form 4, track payout ratios, and see AI-generated red-flag alerts across ALL filing types the moment they hit EDGAR.
Ventas, Inc. (VTR) director Maurice S. Smith reported automatic acquisitions of common stock units on 10/16/2025 from dividend equivalents tied to the company’s dividend paid the same day. The filing shows two credits: 59.484 units under the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 units under the Non-Employee Directors' Equity Award Deferral Program adopted under the 2022 Incentive Plan. The grant price reference was the $69.55 closing price per share as of the grant date. Following these transactions, beneficial ownership was 27,481.871 shares, held directly. The credited units are payable solely in common stock, per plan terms.
Ventas, Inc. (VTR) reported an insider transaction by director Sumit Roy. On October 16, 2025, Roy acquired 49.89 common stock units via the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 common stock units via the Non-Employee Directors' Equity Award Deferral Program. These units were credited as dividend equivalents tied to the company’s dividend paid on that date and are payable solely in common stock. The reference price for the grants was $69.55, the closing price on the grant date.
Following the reported transactions, Roy beneficially owned 21,339.344 shares, held directly.
Ventas, Inc. filed a Form 4 reporting an insider share acquisition. Director Joe V. Rodriguez, Jr. acquired 46.173 common stock units on 10/16/2025 as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. These units are payable solely in common stock. The closing price per share as of the grant date was $69.55. After the transaction, he beneficially owned 7,764.461 shares, held directly.
Ventas, Inc. (VTR) reported an insider transaction by a director. On October 16, 2025, the reporting person acquired 74.76 units of common stock credited as dividend equivalents under the Ventas Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. The units are payable solely in common stock, using the $69.55 closing price per share as of the grant date. After this transaction, the reporting person beneficially owned 21,290.153 shares, held directly.
Ventas (VTR): Director Roxanne M. Martino reported an acquisition of 201.433 shares of common stock on 10/16/2025, credited as dividend-equivalent units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan. The grant is payable solely in common stock and reflects the dividend paid on October 16, 2025. The price reference was the $69.55 closing price on the grant date. After this transaction, her beneficial ownership is 62,417.095 shares, held directly.
Ventas (VTR) director Matthew J. Lustig reported routine acquisitions of common stock units on October 16, 2025 from dividend equivalents credited under director deferral programs. He received 250.738 units under the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 units under the Non-Employee Directors' Equity Award Deferral Program, each valued at the closing price of $69.55 per share as of the grant date. After these credits, he directly beneficially owned 91,546.943 shares.
Ventas, Inc. (VTR): Director Michael J. Embler acquired 74.76 units payable in common stock on October 16, 2025 as dividend equivalents under the Non‑Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. The transaction was coded “A” (acquisition) in Table I. The filing notes a reference price of $69.55 per share as of the grant date. After this credit, Embler beneficially owned 14,520.153 shares, held directly.
Ventas, Inc. (VTR) director Melody C. Barnes reported an acquisition of 74.76 shares of common stock on 10/16/2025. The shares reflect units credited as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program and are payable in common stock, consistent with her deferral election.
The filing cites a closing price of $69.55 per share on the grant date. After this transaction, Barnes directly owned 33,125.153 shares.
Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), reported transactions dated 10/01/2025 on Form 4 showing the exercise and sale of 10,322 shares. She exercised fully vested stock options with an exercise price of $65.45 that were exercisable from 05/04/2016 and scheduled to expire 05/04/2026. The shares were sold under a Rule 10b5-1 trading plan entered 03/28/2024 at a weighted average sale price of $70.237. After the transactions, her reported beneficial ownership was 1,145,695 shares and she holds 670,965 unexercised options.
Peter J. Bulgarelli, an executive at Ventas, Inc. (VTR), reported two open-market sales executed under a Rule 10b5-1 trading plan entered on February 20, 2025. On 09/30/2025 he sold 2,040 shares at $69.99, reducing his stake to 119,042 shares. On 10/01/2025 he sold 2,554 shares at a weighted-average price of $70.2566, leaving him with 116,488 shares. The filing states the 10b5-1 plan covers these sales and discloses the reported price range of $69.9931 to $70.4706, with the reporting person offering to provide detailed per-trade quantities on request.
FAQ
What is the current stock price of Ventas (VTR)?
What is the market cap of Ventas (VTR)?
